Charles R. Kaye, co-CEO at Warburg Pincus, discusses the growing importance of Asia to his firm, valuation bubbles in the technology space, and changes in the GP-LP relationship
Q: What key trends do you see in US private equity? A: The key topic everybody is talking about these days is abundant capital. It feels as though we live in a world where savings are outrunning investment...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.